Estados financieros detallados de Ginkgo Bioworks Holdings, Inc. (DNA): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Ginkgo Bioworks Holdings, Inc. registró ingresos de $170.2M en el último ejercicio fiscal, con un CAGR de 5 años del 17.3%.
Márgenes de los últimos 12 meses: margen bruto 80.1%, margen operativo -259.9%, margen neto -260.0%.
Al precio actual de $7.06, DNA presenta beneficios negativos (P/E no significativo) y un ROE del -60.21%. La capitalización bursátil es de $461M.
Cuenta de Resultados (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $54.2M | $76.7M | $313.8M | $477.7M | $251.5M | $227.0M | $170.2M |
| Coste de Ventas | 0 | $15.6M | $129.7M | $204.2M | $54.0M | $38.5M | $31.5M |
| Beneficio Bruto | $54.2M | $61.0M | $184.1M | $273.5M | $197.4M | $188.5M | $138.6M |
| I+D | $96.3M | $159.8M | $1.15B | $1.05B | $580.6M | $424.1M | $243.8M |
| Generales y Administrativos | $29.5M | $38.3M | $863.0M | $1.43B | $385.0M | $246.2M | $183.3M |
| Gastos Operativos | $125.8M | $198.1M | $2.01B | $2.48B | $1.06B | $748.3M | $453.9M |
| Beneficio Operativo | -$71.6M | -$137.0M | -$1.83B | -$2.21B | -$864.4M | -$559.8M | -$315.3M |
| EBITDA | -$106.7M | -$108.6M | -$1.81B | -$2.06B | -$821.3M | -$484.4M | -$254.6M |
| Gastos por Intereses | $2.4M | $2.4M | $2.4M | $106000 | $93000 | $94000 | 0 |
| Beneficio Antes de Impuestos | -$119.8M | -$124.8M | -$1.84B | -$2.12B | -$892.9M | -$547.5M | -$313.6M |
| Impuestos | $22000 | $1.9M | -$1.5M | -$15.0M | -$71000 | -$479000 | -$837000 |
| Beneficio Neto | -$119.3M | -$126.6M | -$1.83B | -$2.10B | -$892.9M | -$547.0M | -$312.8M |
| BPA | $-4.15 | $-3.97 | $-53.83 | $-50.15 | $-18.37 | $-10.54 | $-5.64 |
| BPA Diluido | $-4.15 | $-4.00 | $-55.53 | $-50.20 | $-18.40 | $-10.54 | $-5.64 |
| Acciones en Circulación (Diluidas) | $28.7M | $31.9M | $34.0M | $42.0M | $48.6M | $51.9M | $55.5M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $38.8M | $33.4M | $19.5M | $20.2M |
| Beneficio Bruto | $26.0M | $41.5M | $3.6M | $18.4M |
| Beneficio Operativo | -$90.0M | -$70.8M | -$71.4M | -$58.5M |
| EBITDA | -$66.6M | -$34.9M | -$63.3M | -$44.4M |
| Beneficio Neto | -$80.8M | -$80.8M | -$82.6M | -$46.7M |
| BPA | $-1.45 | $-1.43 | $-1.39 | $-0.75 |
| BPA Diluido | $-1.45 | $-1.43 | $-1.39 | $-0.75 |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $495.3M | $380.8M | $1.55B | $1.32B | $944.1M | $561.6M | $167.2M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | $255.4M |
| Cuentas por Cobrar | $7.7M | $21.9M | $149.9M | $84.0M | $17.9M | $22.4M | $24.0M |
| Inventario | 0 | $9.3M | $3.4M | $4.4M | $46000 | 0 | 0 |
| Activos Corrientes | $511.9M | $426.5M | $1.72B | $1.45B | $1.00B | $602.7M | $471.8M |
| Inmovilizado Material | $63.1M | $121.4M | $145.8M | $718.8M | $395.0M | $598.2M | $528.7M |
| Fondo de Comercio | $1.9M | $1.9M | $21.3M | $60.2M | $49.2M | 0 | 0 |
| Activos Intangibles | $3.8M | $3.3M | $21.6M | $111.0M | $82.7M | $72.5M | $56.9M |
| Activos Totales | $697.3M | $675.2M | $2.07B | $2.54B | $1.67B | $1.38B | $1.12B |
| Cuentas por Pagar | $2.4M | $13.9M | $8.2M | $10.5M | $9.3M | $14.2M | $10.6M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $40.1M | $73.2M | $134.8M | $173.0M | $163.9M | $107.3M | $96.0M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $195.5M | $205.1M | $503.6M | $803.0M | $568.2M | $661.4M | $611.1M |
| Reservas | -$341.3M | -$467.9M | -$2.30B | -$4.40B | -$5.29B | -$5.84B | -$6.15B |
| Patrimonio Neto | $493.1M | $461.4M | $1.51B | $1.74B | $1.10B | $716.1M | $508.6M |
| Deuda Total | $17.4M | $17.0M | $23.0M | $442.6M | $239.3M | $467.7M | $439.9M |
| Deuda Neta | -$477.9M | -$363.8M | -$1.53B | -$873.2M | -$704.8M | -$93.8M | $17.3M |
| Capital Circulante | $471.9M | $353.3M | $1.59B | $1.28B | $837.9M | $495.5M | $375.9M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $111.1M | $167.2M | $143.9M | $84.5M |
| Activos Totales | $1.19B | $1.12B | $1.03B | $990.0M |
| Pasivos Totales | $629.4M | $611.1M | $589.9M | $569.8M |
| Patrimonio Neto | $559.8M | $508.6M | $443.2M | $420.3M |
| Deuda Total | $422.9M | $439.9M | $410.7M | $404.1M |
Flujo de Caja (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$119.9M | -$126.7M | -$1.84B | -$2.11B | -$892.9M | -$547.0M | -$312.8M |
| Amortizaciones | $10.8M | $13.9M | $29.1M | $42.6M | $71.6M | $63.0M | $59.0M |
| Compensación en Acciones | $771000 | $476000 | $1.61B | $1.93B | $229.9M | $112.3M | $81.5M |
| Cambio en Capital Circulante | $10.6M | -$26.5M | -$61.5M | -$37.0M | $29.8M | -$89.7M | -$44.1M |
| Flujo de Caja Operativo | -$44.7M | -$135.8M | -$253.8M | -$252.2M | -$295.5M | -$319.6M | -$171.1M |
| Inversiones (CapEx) | -$22.2M | -$57.8M | -$56.5M | -$52.3M | -$40.8M | -$62.5M | -$7.7M |
| Adquisiciones | 0 | 0 | -$12.0M | $26.6M | -$38.6M | -$5.4M | 0 |
| Recompra de Acciones | -$408000 | 0 | -$25.0M | 0 | -$23000 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$66.9M | -$193.7M | -$310.3M | -$304.5M | -$336.3M | -$382.1M | -$178.7M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$31.6M | -$47.7M | -$46.7M | -$44.3M |
| Inversiones (CapEx) | 0 | -$15.3M | -$1.9M | -$2.6M |
| Flujo de Caja Libre | -$31.6M | -$63.0M | -$48.6M | -$46.9M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $17.8M | $21.0M | $15.9M | $7.6M |
Crecimiento y Márgenes (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +41.5% | +309.4% | +52.2% | -47.4% | -9.7% | -25.1% |
| Crecimiento Beneficio Neto (anual) | | -6.1% | -1345.4% | -15.0% | +57.6% | +38.7% | +42.8% |
| Crecimiento BPA (anual) | | +4.3% | -1255.9% | +6.8% | +63.4% | +42.6% | +46.5% |
| Cambio en Acciones (anual) | | +10.9% | +6.7% | +23.5% | +15.8% | +6.8% | +6.9% |
| Crecimiento FCF (anual) | | -189.5% | -60.3% | +1.9% | -10.5% | -13.6% | +53.2% |
| Margen Bruto | 100.0% | 79.6% | 58.7% | 57.3% | 78.5% | 83.0% | 81.5% |
| Margen Operativo | -132.1% | -178.8% | -582.6% | -462.4% | -343.8% | -246.5% | -185.3% |
| Margen EBITDA | -196.8% | -141.7% | -575.7% | -431.2% | -326.6% | -213.3% | -149.6% |
| Margen Neto | -220.2% | -165.2% | -583.1% | -440.6% | -355.1% | -240.9% | -183.8% |
| Margen FCF | -123.4% | -252.6% | -98.9% | -63.7% | -133.7% | -168.3% | -105.0% |
| Tasa Impositiva Efectiva | -0.0% | -1.5% | 0.1% | 0.7% | 0.0% | 0.1% | 0.3% |
Datos por Acción (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-2.33 | $-6.08 | $-9.13 | $-7.25 | $-6.92 | $-7.36 | $-3.22 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $28.7M | $31.7M | $33.0M | $41.9M | $48.5M | $51.9M | $55.5M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -60.21% |
| Rentabilidad sobre capital invertido | -31.63% |
| Rentabilidad sobre activos | -29.37% |
| Margen bruto | 80.09% |
| Margen operativo | -259.86% |
| Margen neto | -259.96% |
Salud financiera
| Deuda / Patrimonio | 0.96 |
| Ratio corriente | 4.57 |
Ratios Clave (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -97.54 | -101.96 | -6.17 | -1.35 | -3.68 | -0.93 | -1.47 |
| P/VC | 23.58 | 27.77 | 7.28 | 1.63 | 2.99 | 0.71 | 0.91 |
| P/V | 214.60 | 167.14 | 34.90 | 5.93 | 13.05 | 2.24 | 2.71 |
| Margen Bruto | 100.0% | 79.6% | 58.7% | 57.3% | 78.5% | 83.0% | 81.5% |
| Margen Operativo | -132.1% | -178.8% | -582.6% | -462.4% | -343.8% | -246.5% | -185.3% |
| Margen Neto | -220.2% | -165.2% | -583.1% | -440.6% | -355.1% | -240.9% | -183.8% |